 |
|
|
| |
CARISEL: A Hybrid Type III Implementation Effectiveness Study of Implementation of Cabotegravir + Rilpivirine Long-Acting (CAB + RPV LA) in European Health Care Settings; Key Clinical and
Implementation Outcomes by Implementation Arm
|
| |
| |
IDWeek 2022 Oct 19-22
Stephane De Wit1, Agathe Rami2, Fabrice Bonnet3, Rebecca DeMoor4, Gilda Bontempo5,
Christine L. Latham5, Martin Gill6, Monica Hadi7, Owen Cooper7, Savita Bakhshi Anand7,
Cassidy A. Gutner5, Mounir Ait-Khaled6, Jean van Wyk6, Maggie Czarnogorski5
|
| |
|
|
|
|
|
